Generex Biotechnology Announces Investor Conference Call Scheduled for July 25, 2019

NEXT STORY
The Hackett Center for Mental Health Names Renowned Mental Health Policy Expert Dr. Gary Blau As New Executive Director
PREV STORY
Valneva Announces Drawdown of Further €10 million from its Existing European Investment Bank Loan
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Generex Biotechnology Announces Investor Conference Call Scheduled for July 25, 2019

NEXT STORY
The Hackett Center for Mental Health Names Renowned Mental Health Policy Expert Dr. Gary Blau As New Executive Director
PREV STORY
Valneva Announces Drawdown of Further €10 million from its Existing European Investment Bank Loan
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Novartis delivers solid growth in second quarter and continues transformation to a focused medicines company

Net sales grew 5% (cc[1], +7% USD) mainly driven by: Cosentyx grew to USD ...

author_avatar
NASDAQ Market News

aTyr Pharma Announces Dosing of First Patient in Phase 2 Trial of ATYR1923 in COVID-19 Patients with Severe Respiratory Complications

author_avatar
NASDAQ Market News

Research Reinforcing the Effectiveness and Safety of the UroLift® System in the Real-World Setting Presented at 50th Annual ICS Meeting

author_avatar
NASDAQ Market News